| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Human Resource Officer
1 company
Lily Cheung is Chief Human Resource Officer at PLRX. Lily Cheung's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $39K at current prices.
The PLRX filings lean toward selling, a net 11,274 shares.
Lily Cheung has 7 Form 4 filings on record from January 2023 to April 2026, all as Chief Human Resource Officer at Pliant Therapeutics (PLRX), 2023–2026.
The 14 reported transactions were 7 option or other derivative awards, 3 dispositions back to the company, 2 open-market sales and 2 stock awards.
Counted by filing, the open-market trades come to no purchases and 2 sales worth about $52K.
The largest open-market sale was 3,740 shares of PLRX at an average $11.20 on January 17, 2025, about $42K. Twelve months later PLRX was down 88%.
Both sales since April 2023 were made under a Rule 10b5-1 trading plan, set up in advance.